Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

1,119

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
Chronic Obstructive Pulmonary Disease COPD
Interventions
DRUG

Glycopyrronium/Formoterol Fumarate

Metered dose inhaler (MDI), contains glycopyrronium/formoterol fumarate fixed-dose combination 7.2/4.8 μg per actuation

DRUG

umeclidinium/vilanterol

Dry powder inhaler (DPI), Each metered dose contains umeclidinium/vilanterol 62.5/ 25μg fixed-dose combination per inhalation

Trial Locations (107)

1002

Research Site, Sofia

1135

Research Site, Budapest

1233

Research Site, Sofia

1407

Research Site, Sofia

1408

Research Site, Sofia

1618

Research Site, Sofia

2600

Research Site, Dupnitsa

2602

Research Site, Dupnitsa

2660

Research Site, Balassagyarmat

2760

Research Site, Razlog

2850

Research Site, Petrich

2900

Research Site, Komárom

3320

Research Site, Kozloduy

3529

Research Site, Miskolc

3700

Research Site, Vidin

4002

Research Site, Plovdiv

4032

Research Site, Debrecen

4080

Research Site, Hajdúnánás

4150

Research Site, Püspökladány

4400

Research Site, Pazardzhik

4700

Research Site, Smolyan

4800

Research Site, Vásárosnamény

5800

Research Site, Pleven

6000

Research Site, Stara Zagora

6305

Research Site, Haskovo

7002

Research Site, Rousse

7300

Research Site, Komló

8582

Research Site, Farkasgyepü

8600

Research Site, Siófok

8800

Research Site, Sliven

9000

Research Site, Varna

9700

Research Site, Szombathely

10455

Research Site, The Bronx

15243

Research Site, Pittsburgh

21001

Research Site, Vinnytsia

21029

Research Site, Vinnytsia

25030

Research Site, Besançon

28054

Research Site, Gastonia

29303

Research Site, Spartanburg

29609

Research Site, Brest

29615

Research Site, Greenville

30046

Research Site, Lawrenceville

31326

Research Site, Rincon

33021

Research Site, Hollywood

33604

Research Site, Pessac

34295

Research Site, Montpellier

36040

Research Site, Poltava

43000

Research Site, Lutsk

43016

Research Site, Dublin

44277

Research Site, Nantes

48336

Research Site, Farmington Hills

51092

Research Site, Reims

58000

Research Site, Chernivtsi

58001

Research Site, Chernivtsi

61002

Research Site, Kharkiv

61035

Research Site, Kharkiv

61058

Research Site, Kharkiv

65025

Research Site, Odesa

69096

Research Site, Zaporizhzhia

69317

Research Site, Lyon

75092

Research Site, Sherman

76012

Research Site, Ivano-Frankivsk

77375

Research Site, Tomball

79066

Research Site, Lviv

85283

Research Site, Tempe

86021

Research Site, Poitiers

92025

Research Site, Escondido

95821

Research Site, Sacramento

109544

Research Site, Moscow

191015

Research Site, Saint Petersburg

191180

Research Site, Saint Petersburg

194291

Research Site, Saint Petersburg

196084

Research Site, Saint Petersburg

197022

Research Site, Saint Petersburg

197342

Research Site, Saint Petersburg

198260

Research Site, Saint Petersburg

214006

Research Site, Smolensk

390005

Research Site, Ryazan

410012

Research Site, Saratov

426035

Research Site, Izhevsk

432009

Research Site, Ulyanovsk

440026

Research Site, Penza

440067

Research Site, Penza

454021

Research Site, Chelyabinsk

620028

Research Site, Yekaterinburg

630051

Research Site, Novosibirsk

634050

Research Site, Tomsk

656038

Research Site, Barnaul

656045

Research Site, Barnaul

T8L 0N2

Research Site, Sherwood Park

R2V 4W3

Research Site, Winnipeg

B2N 1L2

Research Site, Truro

L7M 4Y1

Research Site, Burlington

L7N 3V2

Research Site, Burlington

M9W 4L6

Research Site, Etobicoke

N8X 1T3

Research Site, Windsor

N8X-5A6

Research Site, Windsor

J8Y 6S8

Research Site, Gatineau

G6W 0M5

Research Site, Lévis

G1G 3Y8

Research Site, Québec

G1V 4G5

Research Site, Québec

G3K 2P8

Research Site, Québec

J6E 2B4

Research Site, Saint-Charles-Borromée

H-4031

Research Site, Debrecen

H-6722

Research Site, Szeged

03680

Research Site, Kyiv

04107

Research Site, Kyiv

All Listed Sponsors
collaborator

Parexel International Ltd

UNKNOWN

collaborator

Cognizant Technology Solution

UNKNOWN

collaborator

CISCRP

INDUSTRY

collaborator

eResearchTechnology

INDUSTRY

collaborator

QuintilesIMS Limited

UNKNOWN

collaborator

Corporate Translations Inc

UNKNOWN

lead

AstraZeneca

INDUSTRY

NCT03162055 - Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter